In this study, we showed that a single molecule ppp-VEGF, exerted three distinct antitumor activities, angiogenic inhibition, immune activation and cell death induction, which led to enhanced antitumor efficacy in NSCLC. This evidence concerns the gene VEGFA and non-small cell lung carcinoma.